Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arpad Palfi

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Human Molecular Genetics|April 30, 2002
Murine model of autosomal dominant retinitis pigmentosa generated by targeted deletion at codon 307 of the rds-peripherin geneNiamh McNally, Paul F Kenna, Derrick Rancourt, et al.
International Journal of Molecular Sciences|February 25, 2023
RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD ModelsSophia Millington-Ward, Naomi Chadderton, Laura K Finnegan, et al.
European Journal of Human Genetics : EJHG|June 7, 2012
Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathyNaomi Chadderton, Arpad Palfi, Sophia Millington-Ward, et al.
Human Molecular Genetics|March 5, 2002
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) miceAvril Kennan, Aileen Aherne, Arpad Palfi, et al.
Stem Cell Reports|June 13, 2020
Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal OrganoidsAmelia Lane, Katarina Jovanovic, Ciara Shortall, et al.
International Journal of Molecular Sciences|August 29, 2024
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of GlaucomaSophia Millington-Ward, Arpad Palfi, Ciara Shortall, et al.
Pharmaceutics|February 25, 2023
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial DysfunctionNaomi Chadderton, Arpad Palfi, Daniel M Maloney, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2005
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approachAnna-Sophia Kiang, Arpad Palfi, Marius Ader, et al.
Human Molecular Genetics|April 4, 2008
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10)Lawrence C S Tam, Anna-Sophia Kiang, Avril Kennan, et al.
American Journal of Human Genetics|June 15, 2007
RNA interference-mediated suppression and replacement of human rhodopsin in vivoMary O'Reilly, Arpad Palfi, Naomi Chadderton, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Human Molecular Genetics|April 30, 2002
Murine model of autosomal dominant retinitis pigmentosa generated by targeted deletion at codon 307 of the rds-peripherin geneNiamh McNally, Paul F Kenna, Derrick Rancourt, et al.
International Journal of Molecular Sciences|February 25, 2023
RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD ModelsSophia Millington-Ward, Naomi Chadderton, Laura K Finnegan, et al.
European Journal of Human Genetics : EJHG|June 7, 2012
Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathyNaomi Chadderton, Arpad Palfi, Sophia Millington-Ward, et al.
Human Molecular Genetics|March 5, 2002
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) miceAvril Kennan, Aileen Aherne, Arpad Palfi, et al.
Stem Cell Reports|June 13, 2020
Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal OrganoidsAmelia Lane, Katarina Jovanovic, Ciara Shortall, et al.
International Journal of Molecular Sciences|August 29, 2024
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of GlaucomaSophia Millington-Ward, Arpad Palfi, Ciara Shortall, et al.
Pharmaceutics|February 25, 2023
Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial DysfunctionNaomi Chadderton, Arpad Palfi, Daniel M Maloney, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2005
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approachAnna-Sophia Kiang, Arpad Palfi, Marius Ader, et al.
Human Molecular Genetics|April 4, 2008
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10)Lawrence C S Tam, Anna-Sophia Kiang, Avril Kennan, et al.
American Journal of Human Genetics|June 15, 2007
RNA interference-mediated suppression and replacement of human rhodopsin in vivoMary O'Reilly, Arpad Palfi, Naomi Chadderton, et al.
Pageof 5